AG˹ٷ

STOCK TITAN

[6-K] Haleon plc American Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K
Rhea-AI Filing Summary

Haleon plc reports the purchase and cancellation of 1,200,000 ordinary shares under the second tranche of its share buyback programme announced 31 July 2025. After settlement the company's registered share capital is 8,954,414,051 ordinary shares of £0.01 each, with 1,580,205 held as treasury shares, leaving 8,952,833,846 ordinary shares with voting rights. The announcement notes a full breakdown of individual trades is available via the provided link and on the company website. The notice clarifies it is not an offer for securities and provides contact/signature details for the company secretary.

Haleon plc comunica l'acquisto e la cancellazione di 1.200.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto di azioni annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato della società è costituito da 8.954.414.051 azioni ordinarie del valore nominale di £0,01 ciascuna, di cui 1.580.205 detenute come azioni di tesoreria, lasciando 8.952.833.846 azioni ordinarie con diritto di voto. L'annuncio segnala che una ripartizione dettagliata delle singole transazioni è disponibile tramite il link fornito e sul sito web della società. L'avviso precisa che non si tratta di un'offerta di strumenti finanziari e fornisce i contatti e la firma del segretario societario.

Haleon plc informa sobre la compra y cancelación de 1.200.000 acciones ordinarias en el marco del segundo tramo de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras la liquidación, el capital social registrado de la compañía asciende a 8.954.414.051 acciones ordinarias de £0,01 cada una, con 1.580.205 en autocartera, quedando 8.952.833.846 acciones ordinarias con derecho a voto. El comunicado indica que un desglose completo de las operaciones individuales está disponible en el enlace facilitado y en la web de la compañía. El aviso aclara que no constituye una oferta de valores y proporciona los datos de contacto y la firma del secretario de la empresa.

Haleon plc� 2025� 7� 31� 발표� 자사� 매입 프로그램 � 번째 분할에서 1,200,000 보통�� 취득·소각했다� 보고합니�. 결제 � 회사� 등기 자본금은 액면가 £0.01� 8,954,414,051 보통�이며, 그중 1,580,205주는 자사주로 보유8,952,833,846 보통주에 의결권이 부�됩니�. 공고에는 개별 거래� 전체 내역� 제공� 링크와 회사 웹사이트에서 확인 가능하다고 명시되어 있습니다. 공지� 증권� 대� 제안� 아님� 분명� 하며 회사 비서� 연락� � 서명 정보� 제공합니�.

Haleon plc annonce l'achat et l'annulation de 1 200 000 actions ordinaires dans le cadre du deuxième volet de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré de la société s'élève à 8 954 414 051 actions ordinaires d'une valeur nominale de £0,01 chacune, dont 1 580 205 détenues en actions propres, laissant 8 952 833 846 actions ordinaires avec droit de vote. L'annonce précise qu'une ventilation complète des transactions individuelles est disponible via le lien fourni et sur le site web de la société. L'avis indique qu'il ne s'agit pas d'une offre de titres et fournit les coordonnées et la signature du secrétaire de la société.

Haleon plc meldet den Erwerb und die Vernichtung von 1.200.000 Stammaktien im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms. Nach der Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.954.414.051 Stammaktien zu je £0,01, davon werden 1.580.205 als eigene Aktien gehalten, wodurch 8.952.833.846 stimmberechtigte Stammaktien verbleiben. Die Bekanntmachung weist darauf hin, dass eine vollständige Aufschlüsselung der einzelnen Transaktionen über den bereitgestellten Link und auf der Unternehmenswebseite verfügbar ist. Die Mitteilung stellt klar, dass es sich nicht um ein Angebot von Wertpapieren handelt und enthält Kontakt- und Unterschriftsangaben des Company Secretary.

Positive
  • Share repurchase executed: Purchase and cancellation of 1,200,000 ordinary shares completed under the announced buyback programme
  • Updated capital disclosure: Registered share capital and number of voting shares provided, aiding shareholder notification calculations
  • Regulatory transparency: Full breakdown of individual trades made available in line with Market Abuse Regulation requirements
Negative
  • None.

Insights

TL;DR: Company executed a modest tranche of its announced buyback, updating shares outstanding and voting rights.

The company purchased and cancelled 1.2 million shares under a previously announced buyback programme. This reduces issued share capital to 8.954 billion and leaves 8.9528 billion voting shares. The transaction size is small relative to total share count, so near-term EPS impact will be minimal. Disclosure includes a trade-level breakdown link consistent with market abuse regulation transparency requirements.

TL;DR: Proper regulatory disclosure of share repurchase and updated share capital; routine governance compliance.

The filing follows required transparency protocols by stating shares bought for cancellation, updated capital figures, and providing an itemized trade breakdown. It confirms retained treasury shares and supplies the voting-share figure investors use for notification thresholds. The announcement explicitly disclaims an offer for securities, aligning with standard governance practice.

Haleon plc comunica l'acquisto e la cancellazione di 1.200.000 azioni ordinarie nell'ambito della seconda tranche del programma di riacquisto di azioni annunciato il 31 luglio 2025. Dopo il regolamento, il capitale sociale registrato della società è costituito da 8.954.414.051 azioni ordinarie del valore nominale di £0,01 ciascuna, di cui 1.580.205 detenute come azioni di tesoreria, lasciando 8.952.833.846 azioni ordinarie con diritto di voto. L'annuncio segnala che una ripartizione dettagliata delle singole transazioni è disponibile tramite il link fornito e sul sito web della società. L'avviso precisa che non si tratta di un'offerta di strumenti finanziari e fornisce i contatti e la firma del segretario societario.

Haleon plc informa sobre la compra y cancelación de 1.200.000 acciones ordinarias en el marco del segundo tramo de su programa de recompra de acciones anunciado el 31 de julio de 2025. Tras la liquidación, el capital social registrado de la compañía asciende a 8.954.414.051 acciones ordinarias de £0,01 cada una, con 1.580.205 en autocartera, quedando 8.952.833.846 acciones ordinarias con derecho a voto. El comunicado indica que un desglose completo de las operaciones individuales está disponible en el enlace facilitado y en la web de la compañía. El aviso aclara que no constituye una oferta de valores y proporciona los datos de contacto y la firma del secretario de la empresa.

Haleon plc� 2025� 7� 31� 발표� 자사� 매입 프로그램 � 번째 분할에서 1,200,000 보통�� 취득·소각했다� 보고합니�. 결제 � 회사� 등기 자본금은 액면가 £0.01� 8,954,414,051 보통�이며, 그중 1,580,205주는 자사주로 보유8,952,833,846 보통주에 의결권이 부�됩니�. 공고에는 개별 거래� 전체 내역� 제공� 링크와 회사 웹사이트에서 확인 가능하다고 명시되어 있습니다. 공지� 증권� 대� 제안� 아님� 분명� 하며 회사 비서� 연락� � 서명 정보� 제공합니�.

Haleon plc annonce l'achat et l'annulation de 1 200 000 actions ordinaires dans le cadre du deuxième volet de son programme de rachat d'actions annoncé le 31 juillet 2025. Après règlement, le capital social enregistré de la société s'élève à 8 954 414 051 actions ordinaires d'une valeur nominale de £0,01 chacune, dont 1 580 205 détenues en actions propres, laissant 8 952 833 846 actions ordinaires avec droit de vote. L'annonce précise qu'une ventilation complète des transactions individuelles est disponible via le lien fourni et sur le site web de la société. L'avis indique qu'il ne s'agit pas d'une offre de titres et fournit les coordonnées et la signature du secrétaire de la société.

Haleon plc meldet den Erwerb und die Vernichtung von 1.200.000 Stammaktien im Rahmen der zweiten Tranche seines am 31. Juli 2025 angekündigten Aktienrückkaufprogramms. Nach der Abwicklung beträgt das eingetragene Grundkapital der Gesellschaft 8.954.414.051 Stammaktien zu je £0,01, davon werden 1.580.205 als eigene Aktien gehalten, wodurch 8.952.833.846 stimmberechtigte Stammaktien verbleiben. Die Bekanntmachung weist darauf hin, dass eine vollständige Aufschlüsselung der einzelnen Transaktionen über den bereitgestellten Link und auf der Unternehmenswebseite verfügbar ist. Die Mitteilung stellt klar, dass es sich nicht um ein Angebot von Wertpapieren handelt und enthält Kontakt- und Unterschriftsangaben des Company Secretary.

 
UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of September 2025
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F
 
Form 40-F
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
09 September 2025 - “Transaction in Own Shares”
 
 
 
99.1
 
 
 
Haleon plc: Transaction in own shares
 
09 September 2025: Haleon plc (the "Company" or "Haleon") today announces the purchase of 1,200,000 ordinary shares of £0.01 each in the Company (the "Shares") for cancellation under the second tranche of its share buyback programme announced on 31 July 2025.
 
 
London Stock Exchange
CBOE (UK)/BXE
CBOE (UK)/CXE
Date of purchase:
08 September 2025
08 September 2025
08 September 2025
Number of Shares purchased:
1,200,000
-
-
Highest price paid per Share (p):
363.6000
-
-
Lowest price paid per Share (p):
358.4000
-
-
Volume weighted average price paid per Share (p):
360.6643
-
-
 
Following the settlement of the above, the Company's registered share capital is 8,954,414,051 ordinary shares of £0.01 each, of which 1,580,205 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,952,833,846 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/4892Y_1-2025-9-8.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
 
About Haleon
Haleon (LSE/NYSE: HLN) is a global leader in consumer health, with a purpose to deliver better everyday health with humanity. Haleon's product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Its long-standing brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren - are built on trusted science, innovation and deep human understanding.
 
For more information, please visit www.haleon.com
 
 
 
 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: September 09, 2025
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary

FAQ

What shares did Haleon (HLN) purchase in this 6-K?

Haleon purchased and cancelled 1,200,000 ordinary shares of £0.01 each under its second tranche buyback.

How many Haleon shares are outstanding and have voting rights after this transaction?

After settlement the company has 8,954,414,051 registered ordinary shares, with 1,580,205 held as treasury shares, leaving 8,952,833,846 voting shares.

Where can I find the detailed trade breakdown for the buyback?

A full breakdown of individual trades is available at the provided London Stock Exchange link and on www.haleon.com/investors.

Does this announcement constitute an offer for securities?

No. The announcement explicitly states it does not constitute or form part of any offer or solicitation for securities.

Was this buyback part of a previously announced programme?

Yes. The purchases were made under the second tranche of the share buyback programme announced on 31 July 2025.
Haleon

NYSE:HLN

HLN Rankings

HLN Latest News

HLN Latest SEC Filings

HLN Stock Data

43.59B
4.47B
0.02%
12.82%
0.39%
Drug Manufacturers - Specialty & Generic
Healthcare
United Kingdom
Weybridge